Fecal Microbiome Associated with Both Colon Adenomas and Lifetime Colorectal Cancer Risk
- 20 August 2022
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 68 (4) , 1492-1499
Abstract
Background Increasing data indicates the gut flora including bacteria and fungi combined with environmental factors are important in the pathogenesis of colorectal cancer (CRC). Understanding differences in the microbiome in patients with colon neoplasia will foster the development of biomarkers for early detection. Aims Determine the association of microbiome with presence of adenomas and predicted CRC risk. Methods In subjects referred for colonoscopy, the NCI CRC risk assessment tool was completed and stool for microbiome analysis as well as fecal immunochemical test (FIT) were collected. We calculated the microbiome alpha diversity using the Shannon index as well as individual bacterial and fungal species. Results Among 34 patients, we identified 10 with one or more adenomas. Only 2 patients were FIT positive. The median predicted lifetime CRC risk was 2.75% and the prevalence of adenoma was higher in the fourth quartile (P < 0.001). The measured alpha diversity was somewhat higher in patients with adenomas (P = 0.07). We identified 4 bacterial species with an increased relative abundance among patients with adenomas [P < 0.5]. Lifetime CRC risk was associated with 2 specific bacterial species, P. distasonis & E. hermannii [P = 0.05 & 0.09, respectively]. No associations were seen with fungal species and adenoma prevalence or lifetime CRC risk. Conclusions In addition to a strong correlation of predicted CRC risk and adenoma prevalence, we also found important differences in specific bacterial species and both adenoma prevalence and CRC risk. Larger trials are needed to potentially implement further data in the clinical setting.Keywords
Funding Information
- Case Comprehensive Cancer Center, Case Western Reserve University
This publication has 17 references indexed in Scilit:
- Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasiaGut, 2016
- Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesionsGenome Medicine, 2016
- Association ofFusobacterium nucleatumwith clinical and molecular features in colorectal serrated pathwayInternational Journal of Cancer, 2015
- The Bacteroides fragilis Toxin Gene Is Prevalent in the Colon Mucosa of Colorectal Cancer PatientsClinical Infectious Diseases, 2014
- Colonization of the Human Gut by E. coli and Colorectal Cancer RiskClinical Cancer Research, 2014
- Human Gut Microbiome and Risk for Colorectal CancerJNCI: Journal of the National Cancer Institute, 2013
- The human mycobiome in health and diseaseGenome Medicine, 2013
- Genomic analysis identifies association of Fusobacterium with colorectal carcinomaGenome Research, 2011
- Fusobacterium nucleatum infection is prevalent in human colorectal carcinomaGenome Research, 2011
- The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological roleJournal of Experimental & Clinical Cancer Research, 2011